e-learning
resources
Vienna 2003
Monday 29.09.2003
Respiratory structure & function: clinical
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of FEV
1
and mid flow parameters as markers of bronchial hyper responsiveness to methacholine
M. P. Swanney, L. E. Beckert, K. A. Sallaway, R. L. Jensen, R. O. Crapo (Christchurch, New Zealand; Salt Lake City, United States Of America)
Source:
Annual Congress 2003 - Respiratory structure & function: clinical
Session:
Respiratory structure & function: clinical
Session type:
Thematic Poster Session
Number:
1798
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. P. Swanney, L. E. Beckert, K. A. Sallaway, R. L. Jensen, R. O. Crapo (Christchurch, New Zealand; Salt Lake City, United States Of America). Comparison of FEV
1
and mid flow parameters as markers of bronchial hyper responsiveness to methacholine. Eur Respir J 2003; 22: Suppl. 45, 1798
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
TB and MDR-TB: what is new in 2012?
An initial investigation by electronic survey of current UK physiotherapy practice into the use and delivery of nebulised isotonic saline
Symptomatic burden of COPD for patients receiving dual or triple therapy
Related content which might interest you:
The accuracy of mid expiratory flow and dysanapsis parameters for evaluation of methacholine provocation test
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009
Effects of inhaled histamine and methacholine on the lung function parameters obtained by spirometry and forced oscillations in asthmatic children
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010
Relationships between bronchial obstruction and differential NO parameters after methacholine challenge testing
Source: Annual Congress 2011 - Lung and airway function
Year: 2011
Comparison of variations of FEV
1
and forced oscillation technique during methacholine challenge
Source: Eur Respir J 2004; 24: Suppl. 48, 339s
Year: 2004
Comparison of bronchodilatator response of FEV
1
and airway resistance
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Year: 2003
Post-bronchodilator changes in volumes and airway caliber according to Peak flow and FEV1 reversibility
Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children
Year: 2019
Comparison of FEV1 and PEF values in cough variant asthma during methacholine challenge test
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010
Assessment of airway responsiveness: Comparison of forced spirometry and body plethysmography for methacholine challenge tests
Source: Annual Congress 2010 - Advances in lung function II
Year: 2010
Comparison of FEV
1
and specific airway conductance in assessing bronchial response to occupational agents
Source: Eur Respir J 2003; 22: Suppl. 45, 488s
Year: 2003
sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011
Maximally attained level of FEV
1
and FEV
1
decline determine airway hyperresponsiveness in adults
Source: Eur Respir J 2003; 22: Suppl. 45, 17s
Year: 2003
How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1
Source: Eur Respir J 2009; 33: 1396-1402
Year: 2009
Can the interrupter resistance be used to measure airway hyperresponsiveness during the methacholine challenge test as a substitute for FEV1?
Source: Virtual Congress 2021 – New insights into lung function testing
Year: 2021
A comparison of the response to inhaled histamine measured with FEV
1
and sGaw in healthy subjects
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Year: 2003
Correlation of biological markers of inflammation in peripheral blood with bronchoprovocative testing with histamine in patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 287s
Year: 2004
Analysis of tidal expiratory flow pattern in the assessment of methacholine-induced bronchoconstriction in adult asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 352s
Year: 2001
Exploring the clinical utility of measuring reversibility in mid expiratory flow and its relationship with FEV1 reversibility in patients with asthma.
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Relationship between pre-bronchodilator FEV1 and ex-vivo intrinsic tone in human small airways
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019
The influence of FVC manoeuvres on consecutive FEV
1
values during methacholine challenge
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept